The effect of dual therapy of pegylated interferon and ribavirin on viral load and liver enzymes of hepatitis C patients / Mohamed Ahmed Abdullah ; Supervised Mona Mahmoud Ezzat , Eman Ahmed Elseidi
Material type:
- تأثير العلاج الثنائى الانترفيرون طويل المفعول و الريبافيرين على تركيز الفيروس و انزيمات الكبد لمرضى الالتهاب الكبدى ج [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.19.M.Sc.2009.Mo.E (Browse shelf(Opens below)) | Not for loan | 01010110052606000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.19.M.Sc.2009.Mo.E (Browse shelf(Opens below)) | 52606.CD | Not for loan | 01020110052606000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Microbiology and Immunology
Chronic hepatitis C infection is recognized as an important health problem worldwide. Approximately 2, 3% of the world population is infected with hepatitis C virus (HCV). Egypt has the highest seroprevalenes for hepatitis C, up to 20% in some areas. Hepatitis C is caused by a small, single-stranded RNA virus. The virus replicates in the liver at a high rate, resulting in average serum HCV RNA levels of 1 to 2 million genome equivalenis per milliliter
Issued also as CD
There are no comments on this title.